26,392 results on '"ETANERCEPT"'
Search Results
2. A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)
3. Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D (COBRA)
4. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants (PROTOSTAR)
5. Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis (PRECISE)
6. A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders (MB04-A-01-23)
7. Korean College of Rheumatology Biologics and Targeted Therapy Registry (KOBIO)
8. Stand UP to Rheumatoid Arthritis (SUPRA) (SUPRA)
9. NATIENS: Optimal Management and Mechanisms of SJS/TEN (NATIENS)
10. Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis (STARA)
11. A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
12. TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset (E/M)
13. CHronic Nonbacterial Osteomyelitis International Registry (CHOIR) (CHOIR)
14. Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis (BIOTAPE)
15. the Efficacy and Safety of Etanercept (Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis
16. Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
17. Association Between Biologic Exposure and the Risk of Depression in Patients with Psoriasis: A Retrospective Analysis of Large US Administrative Claims Data.
18. Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway.
19. Effectiveness and Safety of Etanercept in Paediatric Patients with Plaque-Type Psoriasis: Real-World Evidence.
20. A patient with axial spondylarthritis who experienced pancytopenia while receiving anti-TNF therapy.
21. Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 patients with RA: a matched-analysis of the BSRBR-RA.
22. (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review.
23. Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review.
24. Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis.
25. Dynamics of serum levels of TNF-α in a longitudinal follow-up study in 98 patients with juvenile idiopathic arthritis treated with anti-TNF-α biological drugs.
26. Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?
27. Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis.
28. Charting the Etanercept Journey: Tracing Cost Dynamics in Poland's Off-Patent Market from Reference Drug Rivalry to Biosimilar Monopoly.
29. Analysis of biosimilars consumption in an Italian Local Health Authority.
30. Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
31. Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
32. Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success (COMMIT)
33. Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome (SAPHO)
34. RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
35. COVID-19 VaccinE Response in Rheumatology Patients (COVER)
36. Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
37. Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
38. Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis
39. Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT (2017-00355)
40. Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
41. Advanced Therapeutics in Rheumatoid Arthritis (RA)
42. The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy
43. Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series
44. Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial
45. Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies.
46. Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis.
47. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
48. The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy.
49. Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.
50. Some Drugs Have Two Faces: Paradoxical Colitis in a Patient with Psoriatic Arthritis Previously Treated with Etanercept and IL-17 Inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.